Hirschsprung's disease (HD) is a congenital disorder characterized by the absence of enteric ganglion cells in the distal bowel, leading to functional obstruction, delayed meconium passage in neonates, and chronic defecation difficulties. Surgical intervention is required to remove the aganglionic segment, with minimally invasive laparoscopic techniques increasingly preferred over open surgery due to reduced postoperative complications, shorter hospital stays, and faster recovery. Since 2012, the National Children's Hospital has pioneered the routine use of single-incision laparoscopic surgery (SILS) for HD in Vietnam. However, there is a lack of comprehensive analysis on the operative outcome in this large group of patients. This retrospective study aims to evaluate patient safety profiles, surgical effectiveness, and functional outcomes of minimally invasive laparoscopic procedures for HD performed at the National Children's Hospital between 2017 and 2023.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Volume of Blood Loss
Timeframe: Perioperative
Conversion to open surgery
Timeframe: Perioperative
Operative time
Timeframe: Perioperative
Mortality and severe morbidity
Timeframe: Through study completion, an average of 5 years
Early postoperative complications
Timeframe: Up to 8 weeks post-operation
Time to return of bowel function
Timeframe: Up to 4 weeks post-operation
Rate of reoperation
Timeframe: Through study completion, an average of 5 years
Fecal Continence and Bowel Function Recovery
Timeframe: Through study completion, an average of 5 years
Length of Hospital Stay
Timeframe: Up to 24 weeks post-operation